Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Pluristem Therapeutics Moving Into New State-of-the-art GMP Facility

RELATED NEWS
Trade PSTI now with 

Pluristem Therapeutics, Inc. (PSTI: Quote), a developer of placenta-based cell therapies, Wednesday said the company has taken possession of and is moving into its new state-of-the-art GMP facility.

The facility allows for the production of mass quantities of PLacental eXpanded or PLX cells that possess the advantages of being grown utilizing Pluristem's patented 3D bioreactor technology.

The new manufacturing facility will have the capability to produce different PLX product candidates with the potential capacity of over 150,000 doses annually.

The new facility allows increasing the yield from one placenta to over ten times the yield from the previous pilot facility.

Additionally, if regulators approve more indications for clinical trials, this new facility will enable the firm to supply PLX cells to conduct these additional trials in parallel.

Zami Aberman, Chairman and CEO of Pluristem said, "We are excited to begin work in our new plant. With this new manufacturing facility, our company is capable of combining the ideal characteristics of a supply source in the placenta with a proprietary expansion technology that successfully addresses the issues of reproducibility and cost to provide high numbers of reproducible batches of the highest quality PLX cells.''

Register
To receive FREE breaking news email alerts for Pluristem Therapeutics, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
A bipartisan coalition in the House voted Wednesday evening to approve a measure providing the U.S. military with the authority to train and arm moderate Syrian rebels against the terrorist group known as the Islamic State. The House voted 273 to 156 in favor of the measure, which was attached to a larger spending bill to temporarily fund the government. After moving mostly higher early in the session, stocks have continued to perform well over the course of the trading day on Thursday. The gains on the day have lifted both the Dow and the S&P 500 to new record intraday highs. Firms responding to a survey by the Federal Reserve Bank of Philadelphia indicated continued growth in regional manufacturing activity in September, although the bank said the index of activity in the sector fell from its relatively high reading in August.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.